Answers are grounded in this paper and cite their sources.
Background Hepatocellular carcinoma (HCC) is the third leading cause of cancer death, and its incidence is the end readout of a latent process that begins with hepatocyte injury, inflammation, fibrosis and regenerative proliferation. We treat the tissue layer as the OST triad of outflow, storage and transport, and ask whether a seven-state linear model reproduces SEER incidence, places the triad at H3 and the six product groups at H4, and whether G2 is the upstream priority gate. Methods We built a seven-state model (H, H1-H7, D). Targets were assigned to the O, S and T axes by measured function, and PubMed records measured evidence volume and coverage. The model was calibrated to SEER 2012–2016 age-specific incidence, and AIC, BIC and leave-one-age-group cross-validation compared the one-state, three-state and seven-state structures. Results The seven-state model reproduced the age-specific incidence (AIC 27.14), within 0.75 AIC units of the one-state model and better than the three-state model (39.95). The OST triad covered 80 targets and 10,284 records, and the H4 groups covered 58 targets and 10,092 records. G2 was the upstream priority gate, and state occupancy followed H1-H7. Conclusion The tissue layer of HCC is the OST triad. H3 is the triad, H4 is the product layer, and G2 is the upstream priority gate. The seven-state model resolves H1-H7; H4 to H5 is the cell-mutation axiom, and H5-H7 is the established mutation-clone chain.
No takes yet. Share an insight, caveat, or question.
wei qiaoxuan (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: